GWINGlorywin Entertainment Group, Inc.
Price Chart
Loading chart...
About Glorywin Entertainment Group, Inc. (GWIN)
Glorywin Entertainment Group, Inc. (GWIN) is a Biotechnology company headquartered in Denton, TX, United States whose shares trade over-the-counter on the Pink tier.
Reska Biotech, Inc. is a 3D bioprinting technology research and development, anti-cancer drug research and development.
Products and services
Glorywin Entertainment Group, Inc. (GWIN) is principally engaged in manufacturing and supplying of high-grade wood pellets in Malaysia. Malaysia is a country with resourceful of renewable energy commodity, such as EFB fibre, saw dust, straw, rice husk and wood chip. This has make Malaysia a source of pellet supplier. GWIN is planning to expand the business into manufacturing and supplying different types of biomass fuels in the future.
GWIN key facts
- Ticker symbol
- GWIN
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Denton, TX, United States
- Country of incorporation
- US
- Year of incorporation
- 2010
- Employees
- 4
- Estimated market cap
- $59.70M (as of May 12, 2025)
- Shares outstanding
- 356,194,747
- Reporting standard
- Alternative Reporting Standard
- Audit status
- Unaudited
- Fiscal year end
- 3/31
- Latest filing
- Quarterly Report (Dec 31, 2024)
Glorywin Entertainment Group, Inc. leadership
- Sorphea Rath — CEO
- Solin Hoem — CFO
- Jiami Cheng — Vice President
- Caren D Currier — Consultant
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with G
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Glorywin Entertainment Group, Inc. (GWIN) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...